<table class="naaccr-summary-table naaccr-borders">
  <tr>
    <th class="naaccr-summary-header naaccr-borders">Item #</th>
    <th class="naaccr-summary-header naaccr-borders">Length</th>
    <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
    <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
    <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
  </tr>
  <tr>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">3,857</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">NAACCR</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2018</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">18</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
  </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.highRiskCytogenetics<br/><br/>

<div class='content chap10-para-head'><strong>Description</strong></div>
<div class='content chap10-para'>
<p>High Risk Cytogenetics is defined as one or more of t(4;14), t(14;16), or del 17p identified from FISH test results and is part of the staging criteria for plasma cell myeloma.</p>

</div>

<div class='content chap10-para-head'><strong>Rationale</strong></div>
<div class='content chap10-para'>
<p>High Risk Cytogenetics is a prognostic factor required in AJCC 8th edition, Chapter 82 <em>Plasma Cell Myeloma and Plasma Cell Disorders</em>, for staging of plasma cell myeloma.</p>

</div>



<div class='content chap10-para'><p><strong>Codes</strong></p>
</div>
<table>
        <tr class='code-row'><td class='code-nbr'>0</td><td class='code-desc'>High-risk cytogenetics not identified/not present</td></tr>
        <tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>High-risk cytogenetics present</td></tr>
        <tr class='code-row'><td class='code-nbr'>5</td><td class='code-desc'>Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9</td></tr>
        <tr class='code-row'><td class='code-nbr'>7</td><td class='code-desc'>Test ordered, results not in chart</td></tr>
        <tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record  
 High Risk Cytogenetics not assessed or unknown if assessed</td></tr>
</table>

<div class='content chap10-para'>
<p>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</p>

</div>
